Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial

BACKGROUND: In a previous randomised controlled phase 2 trial, intravenous infusion of salbutamol for up to 7 days in patients with acute respiratory distress syndrome (ARDS) reduced extravascular lung water and plateau airway pressure. We assessed the effects of this intervention on mortality in pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Smith, Fang Gao, Perkins, Gavin D, Gates, Simon, Young, Duncan, McAuley, Daniel F, Tunnicliffe, William, Khan, Zahid, Lamb, Sarah E
Médium: Artigo
Jazyk:Inglês
Vydáno: Lancet Publishing Group 2012
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3266479/
https://ncbi.nlm.nih.gov/pubmed/22166903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(11)61623-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky